Searchable abstracts of presentations at key conferences in endocrinology

ea0009p43 | Growth and development | BES2005

Kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis in adult male rats following central and peripheral administration

Thompson E , Patterson M , Murphy K , Smith K , Dhillo W , Todd J , Ghatei M , Bloom S

Kisspeptin is the peptide product of the KiSS-1 gene and endogenous agonist for the GPR54 receptor. The kisspeptin/GPR54 system has recently been suggested as a key regulator of the reproductive system. GPR54 deficient mice have abnormal sexual development and low circulating gonadotrophins and in humans, GPR54 mutations have been shown to cause hypogonadotrophic hypogonadism. Thus, GPR54 appears to be essential for normal gonadotrophin secretion and the regulation of puberty....

ea0007oc12 | Development and growth | BES2004

Alterations of the somatotrophic axis in the obese agouti (Ay/a) mouse

Martin N , Houston P , Patterson M , Carmignac D , Ghatei M , Bloom S , Small C

In addition to obesity, models of abnormal hypothalamic melanocortin signalling display increased linear growth, although the mechanism remains unclear. We have studied the somatotrophic axis in the obese agouti (Ay/a) mouse (male, 12-14 weeks), as a model of an altered melanocortin system. Somatotrophic hormones were measured by radioimmunoassay and hypothalamic neuropeptide expression studied by in situhybridisation.Obese A<...

ea0038p269 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Improving glycaemic control in T1DM: the Fife Insulin and Food Education for Diabetes (FIFE Diabetes) structured education programme

Boyle Luke , Jamieson Fiona , Burns Denise , Duncan Katie , Malcolm Jill , White Leslie , Chalmers John , Osborne Louise , Patterson Catherine

Background: The 2013 Scottish Diabetes Survey demonstrated that only 22% of individuals with type 1 diabetes have optimal glycaemic control, defined as a HbA1c <58 mmol/mol. The 2014 Diabetes Improvement Plan in Scotland prioritised, ‘improving the care and outcomes of all people living with type 1 diabetes’. Scotland’s Diabetes Education Advisory Group has now been established. Accordingly, the Fife Insulin and Food Education for Diabetes (FIFE Diabetes) st...

ea0025p192 | Endocrine tumours and neoplasia | SFEBES2011

Familial adrenocortical carcinoma associated with HNPCC

Kandasamy Narayanan , Nik-Zainal Serena , Annamalai Anand Kumar , Walker Lisa , Happerfield Lisa C , Arends Mark J , Patterson Joan , Gurnell Mark

We report the first case of familial adrenocortical carcinoma (ACC) in association with hereditary non-polyposis colorectal cancer (HNPCC) in a family with a MSH2 germline mutation.HNPCC, an autosomal dominant disorder caused by mutations in one of the DNA mismatch repair (MMR) genes, is the commonest cause of hereditary colon carcinoma, and is associated with an increased risk of certain non-colonic cancers (e.g. endometrial, ovarian, urin...

ea0021p239 | Neuroendocrinology and behaviour | SFEBES2009

Alarin stimulates food intake and the hypothalamo-pituitary–gonadal axis in male rats

Boughton Charlotte , Patterson Michael , Bewick Gavin , Tadross John , Gardiner James , Chaudery Faizan , Hunter George , Ghatei Mohammad , Bloom Stephen , Murphy Kevin

Alarin is the most recently discovered member of the galanin peptide family, and is encoded by a splice variant of galanin-like peptide (GALP) mRNA. Galanin and GALP are known to regulate energy homeostasis and reproduction. Galanin is thought to mediate its effects via the three-galanin receptors. GALP also binds to these known galanin receptors, but evidence suggests that it may also act via an as yet unknown GALP specific receptor. The role of alarin in energy homeostasis a...

ea0015p95 | Clinical practice/governance and case reports | SFEBES2008

Impact of NICE guidelines for adult growth hormone replacement on practice in Scotland

Philip Sam , Howat Isabel , Carson Maggie , Booth Anne , Patterson Catherine , Schofield Christopher , Patrick Alan , Leese Graham , Bevan John , Connell John

Aim: To assess whether adults in Scotland currently receiving growth hormone (GH) meet the NICE criteria for starting and continuing GH replacement.Methods: We surveyed all endocrinologists in Scotland and identified the main centres using GH replacement. A cross-sectional case note review was carried out of all patients commenced on GH.Results: About 208 patients (51% women; 24% professionals, 90% Caucasian) were identified, 69 of...

ea0015p281 | Reproduction | SFEBES2008

Pre-analytical factors affecting measurement of plasma kisspeptin by radioimmunoassay

Ramachandran Radha , Patterson Michael , Murphy Kevin G , Dhillo Waljit S , Patel S , Kazarian A , Ghatei Mohammad A , Bloom Stephen R

Background: Kisspeptin is a peptide product of the KiSS-1 gene and a key regulator of the hypothalamo-pituitary-gonadal axis. Pregnancy is associated with raised plasma kisspeptin concentrations. However, there is significant variation in the plasma kisspeptin levels quoted in previous studies. We investigated the effects of pre-analytical factors including processing time and anticoagulant type on plasma kisspeptin-immunoreactivity (IR) measurement.Meth...

ea0013p93 | Clinical practice/governance and case reports | SFEBES2007

NICE Guidelines for Adult Growth Hormone replacement: an audit of impact on practice in Scotland

Philip S , Carson M , Howat I , Patterson C , Schofield C , Booth A , Patrick AW , Leese GW , Bevan JS , Connell JMC

Background: National Institute for Clinical Excellence (NICE) guidelines for the use of Growth Hormone (GH) replacement in adults with GH deficiency (GHD) were published in 2003, and subsequently ratified for use in Scotland.Aim: To identify all adults in Scotland currently receiving GH and to assess whether they meet the NICE criteria for starting and continuing GH replacement.Methods: All endocrinologists in Scotland were surveye...

ea0012p92 | Reproduction | SFE2006

Continuous administration of kisspeptin-54 leads to desensitisation of the hypothalamo-pituitary-gonadal axis and testicular degeneration

Appleby GF , Thompson EL , Murphy KG , Patterson M , Bewick GA , Stamp GWH , Todd JF , Ghatei MA , Bloom SR

Kisspeptin-54 is a neuropeptide encoded by the Kiss-1 gene with an important role in the regulation of reproduction and puberty. Acute peripheral or intra-hypothalamic administration of kisspeptin-54 potently stimulates the hypothalamo-pituitary-gonadal (HPG) axis via hypothalamic gonadotrophin releasing hormone (GnRH) neurons. However, the effects of chronic continuous kisspeptin administration are poorly characterised. Our studies investigated the effects of chronic, continu...

ea0011p690 | Reproduction | ECE2006

Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats

Thompson EL , Murphy KG , Patterson M , Bewick GA , Jethwa PH , Stamp GWH , Todd JF , Ghatei MA , Bloom SR

The kisspeptins are KiSS-1 gene-derived peptides which signal through the G protein coupled receptor 54 (GPR54), and have recently been shown to be critical regulators of reproduction. Acute intracerebroventricular (ICV) or peripheral administration of kisspeptin to rodents and primates, and peripheral administration to humans, stimulates the hypothalamic-pituitary gonadal (HPG) axis. This effect is thought to be mediated via the hypothalamic gonadotrophin-releasing hormone (G...